Vascular Surgery at Nice University Hospital: A New, Innovative Piece of Equipment

chu nice allia igs

A Medical First at the CHU de NiceNice University Hospital (CHU de Nice) has welcomed its first patient into the Allia IGS 7 hybrid operating room — a next-generation surgical space located at the Pasteur 2 hospital site. This cutting-edge room combines advanced imaging and robotics, providing a unique working environment for surgical teams. A […]

MyHealthFriend: a Franco-Italian app for preventive health and well-being

appli myhealthfrience

The Nice University Hospital (CHU de Nice) is coordinating the MyHealthFriend project as part of the Interreg Alcotra France–Italy 2021–2027 programme. The initiative brings together the Italian health agencies ASL CN1 and ASL CN2. This free mobile application aims to promote preventive health and overall well-being. The project has a total budget of €2 million, […]

Circum Medtech Pharma expands its industrial development in Tunisia from Nice

circum medtech pharma

Circum Medtech Pharma is a CDMO specialized in medical devices, active across the entire value chain. Established in Nice since 2024, Circum Medtech Pharma will inaugurate its new plant in Sousse (Tunisia) on October 2, 2025. This new site structures its presence between Nice, Zurich and Sousse, within a Euro-Mediterranean value chain. Based in Nice, […]

TIGER e-health: the Côte d’Azur integrates into alpine innovation

tiger e-santé : la côte d’azur s’intègre à l’innovation alpine

A budget of €2.67 million finances the TIGER program in the Alpine space. It supports innovation in connected health. The Côte d’Azur is part of this European initiative. The Nice Côte d’Azur Chamber of Commerce and Industry and Eurobiomed support local companies. They facilitate access to European funding. SMEs benefit from support at every stage […]

The Nice-based biotech Roca Therapeutics reaches a new milestone in its development

biotech niçoise Roca Therapeutics

A European recognition for a neglected disease: Roca Therapeutics has obtained from the European Medicines Agency (EMA) the orphan drug designation for its drug candidate RCT002. This status marks the official recognition of radiation maculopathy as a disease in its own right, after having long been considered only a complication. This advancement enables reinforced regulatory […]

Health Afterwork in Nice: connecting innovators in the HealthTech sector

Afterwork-Life-Science-Nice-Cote-dAzur-2

Team Nice Côte d’Azur, with the commitment of Sana Bouyahia, Head of Project Development Health and Sports, organized a structuring afterwork event to strengthen synergies among stakeholders in the health sector. The initiative was launched by Medpackinter, a new pharmaceutical manufacturer established in Nice in 2024 with the support of Team Nice Côte d’Azur, as […]

Paul Martingell new Chief Executive Officer of the Virbac Group

Paul Martingell nommé directeur général du groupe Virbac

Virbac announces the appointment of Paul Martingell as chief executive officer of the Virbac Group, effective September 1, 2025. Paul Martingell, 45, is a recognized leader who has demonstrated his ability to unite international teams, manage complexity, and create value. Holder of an MBA with distinction in mergers and acquisitions and a chartered accountant in […]